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Background: Sex and gender differences are often overlooked in research design, study implementation and
scientific reporting, as well as in general science communication. This oversight limits the generalizability of
research findings and their applicability to clinical practice, in particular for women but also for men. This article
describes the rationale for an international set of guidelines to encourage a more systematic approach to the
reporting of sex and gender in research across disciplines.
Methods: A panel of 13 experts representing nine countries developed the guidelines through a series of
teleconferences, conference presentations and a 2-day workshop. An internet survey of 716 journal editors,
scientists and other members of the international publishing community was conducted as well as a literature
search on sex and gender policies in scientific publishing.
Results: The Sex and Gender Equity in Research (SAGER) guidelines are a comprehensive procedure for reporting
of sex and gender information in study design, data analyses, results and interpretation of findings.
Conclusions: The SAGER guidelines are designed primarily to guide authors in preparing their manuscripts, but
they are also useful for editors, as gatekeepers of science, to integrate assessment of sex and gender into all
manuscripts as an integral part of the editorial process.
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Sex and gender are important determinants of health
and well-being. Sex refers to a set of biological attributes
in humans and animals that are associated with physical
and physiological features including chromosomes, gene
expression, hormone function and reproductive/sexual
anatomy [1]. Sex is usually categorized as female or male,
although there is variation in the biological attributes that
constitute sex and how those attributes are expressed.
Gender refers to the socially constructed roles, behav-
iours and identities of female, male and gender-diverse
people [1]. It influences how people perceive themselves
and each other, how they behave and interact and the
distribution of power and resources in society. Gender is* Correspondence: babor@uchc.edu
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(http://creativecommons.org/publicdomain/zeusually incorrectly conceptualized as a binary (female/
male) factor. In reality, there is a spectrum of gender
identities and expressions defining how individuals iden-
tify themselves and express their gender. A glossary of
terms is provided in Appendix 1 to define the meaning
of sex, gender and related terms.
Sex and gender interactions influence health and well-
being in a variety of ways. They both impact environ-
mental and occupational risks, risk-taking behaviours,
access to health care, health-seeking behaviour, health
care utilization, and perceived experience with health care,
and thus disease prevalence and treatment outcome. In
addition, it is well-known that pharmacokinetics and
pharmacodynamics of pharmaceutical agents differ be-
tween sexes, resulting in differential adverse event profiles
and further impacting treatment outcomes. Thus, sex and
gender are critical determinants of health [2].is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Despite recognition of the importance of sex and gender
in most areas of research, important knowledge gaps
persist owing to the general orientation of scientific
attention to one sex or gender category and because of
a misconception that disaggregation of sex does not
apply to other living organisms that can be classified
by sex [3–6].
The gap in the representation of women in studies on
human subjects has been well-documented [1]. A review
of cardiovascular treatment trials included in Cochrane
Reviews reveals that only 27 % of the total trial partici-
pants in the 258 clinical trials were women [7]. More
importantly, among trials recruiting both men and
women, only one third reported a gender-based analysis
[8]. More than 79 % of animal studies published in Pain
over a 10-year period included male subjects only, and
only 4 % studied sex differences [9].
The underrepresentation of women in research can result
in adverse consequences. Among the ten prescription phar-
maceuticals withdrawn from the US market between 1997
and 2001, eight caused greater harm to women than men
[10]. More recently, the US Food and Drug Administration
(FDA) issued a safety communication, recommending half
a dose of zolpidem for women, due to greater susceptibility
to the risks of the drug [11]. Sex- and gender-based
analysis, in all of these cases, would have provided suf-
ficient information to guide dosing and applicability of
drugs in men and women prior to approval.
Failure to conduct sex and gender-based analysis occurs
in a range of disciplines. In the field of engineering, lack of
consideration of differences in the physiology and anatomy
of males and females in developing car seats has resulted in
higher risk for whiplash injuries among female car occu-
pants compared with men [12, 13].
Although the term “gender gap” has most often been
applied to women, the benefit that sex- and gender-based
analysis has for our understanding of men’s health should
also be noted. Despite the increasing representation of
male and female subjects in research and reporting of sex-
specific and gender-specific data, these examples indicate
that existing policies have not been enforced [3]. Lack
of interest in sex and gender differences may not only
be harmful but also present missed opportunities for
innovation. Understanding the underlying differences
and similarities, exploring applicability, uptake and im-
pact of technological innovations and getting deeper
insight into cognitive variability will undoubtedly lead
to more innovative approaches and better solutions to
meet the needs of society.
The role of journal editors and editorial policies
Editors play an important role as gatekeepers of science,
including the articulation of an ethical framework thatinfluences the conduct of research. With an ever-increasing
volume of information being published, concerns over the
quality of publications have lead journal editors, publishers
and professional associations to implement detailed guide-
lines. Ethical review procedures are now universally applied
in human and animal research, in part because of journal
requirements. The impact of journal policies on compliance
to mandates has been clearly demonstrated in such diverse
areas as clinical trial registration [14] and the reporting of
systematic reviews after introduction of PRISMA guidelines
[15]. Another illustration is the gradual adoption of the
Consolidated Standards of Reporting Trials (CONSORT)
statement, which has led to improved reporting of random-
ized controlled trials [16, 17]. Following CONSORT and
PRISMA, many other reporting guidelines have been
developed, including the ARRIVE guidelines for animal
research [18].
Although policy implementation and enforcement con-
tinue to be a critical challenge, journals could play an
important role in advancing the quality and transparency
of reported data by promoting sex- and gender-specific
analysis of research data as a matter of routine. In a 2011
workshop on “Sex-specific reporting of scientific re-
search,” convened by the US Institute of Medicine, a
number of key issues were identified that journals and
journal editors should address in order to improve
gender-sensitive reporting of research [3], including the
appropriateness of sex-specific data analyses and the
absence of journal policies recommending sex and gen-
der considerations in research design and reporting.
On the basis of the available evidence, a committee of
the US Institute of Medicine in 2010 recommended that
the International Committee of Medical Journal Editors
(ICMJE) and other editors adopt a guideline that all
papers reporting the results of clinical trials analyse
data separately for men and women. The ICMJE has
since published more robust guidance on sex and gen-
der reporting, recommending that researchers include
representative populations in all study types, provide
descriptive data for sex and other relevant demographic
variables and stratify reporting by sex [19].
Adequate inclusion of sufficient numbers of men and
women (and other sub-populations) in research, along
with appropriate analysis and transparent and complete
reporting of research data, require a concerted effort
among funders, researchers, reviewers and editors [20].
Although editors typically enter the research process
late, after the research has already been concluded and
the data analysed, they can still play an important role in
ensuring effective, transparent and complete sex and
gender reporting.
In recent years, several reviewers of sex and gender is-
sues in scientific research have made recommendations
regarding the best ways to address the problems that
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the methodology of systematic reviews and of sex- and
gender-based analyses be refined and synchronized to
enhance the collection, synthesis and analysis of evidence
for decision-making, and they developed an appraisal tool
for systematic reviews and adapted it to evaluate primary
studies and protocols for new research [22]. Nowatski and
Grant [23] provided a rationale for gender-based analysis,
which is designed to identify the sources and conse-
quences of inequalities between women and men and to
develop strategies to address them. The Clinical Orthope-
dics and Research journal published an editorial on gender
and sex in scientific reporting in 2014, including a set of
recommendations [5].
Editorial associations, publishing houses, funding agen-
cies and public interest organizations have also taken an
interest in sex and gender issues. The Canadian Institutes
of Health Research implemented a requirement in 2010
that all grant applicants respond to mandatory questions
about whether their research designs include gender and
sex [24]. Advances made in the inclusion of women as re-
search participants in the USA can be attributed in large
part to the actions taken at the NIH in 1993 that stipu-
lated women and minorities should be included in phase 3
clinical trials so that valid analyses of differences in inter-
vention effects could be performed [25]. More recently,
the NIH announced plans to require grant applicants to
describe how they will balance of male and female cells
and animals in preclinical studies, unless sex-specific in-
clusion is unwarranted [6].
Despite a greater recognition of the importance of sex
and gender considerations in research and scientific
publishing, progress has been slow in some areas of sci-
ence and further work is needed to build on preceding
efforts by journals, journal editors and learned societies.
As noted by Nieuwenhoven [26], vigorous approaches
are needed to stimulate scientists to integrate sex and
gender aspects into their research. For example, there is
no overarching set of recommendations that provides
guidelines for better reporting of sex and gender in sci-
entific publications across disciplines. To address this
need, the present article describes the development of a
set of international guidelines to encourage a more sys-
tematic approach to the reporting of sex and gender in
research across disciplines.
Methods
The European Association of Science Editors (EASE)
established a Gender Policy Committee in 2012 and
tasked it to develop a set of guidelines for reporting of
Sex and Gender Equity in Research (SAGER). A panel of
13 experts (eight females, five males) representing nine
countries were selected by the Chairperson of the GPC
(Dr. Heidari). Eight members were senior editors for avariety of biomedical journals, and the remaining indi-
viduals had expertise on gender research and scientific
publishing.
An internet survey of 716 journal editors, scientists
and other members of the international publishing com-
munity was first conducted to gather information about
existing sex and gender policies and opinions about the
need for such policies. The survey focused on four policy
areas: (1) instructions for authors that require or encour-
age disaggregation of data by sex or gender when feas-
ible; (2) gender policies concerning the composition of
editorial staff and boards; (3) policies that strive for gen-
der balance among peer reviewers and (4) guidelines
that ask reviewers to assess manuscripts for inclusion
of sex-disaggregated data and gender analysis. The sur-
vey targeted four groups: EASE members; members of
the International Society of Addiction Journal Editors
(ISAJE); a random sample of 100 journals selected from
the 8607 names in the Thomson Reuters SCI Expanded
database of journals and an open sample in which any
concerned individual could complete the survey. In
total, 716 respondents took part in the survey, repre-
senting 338 unique journals and 114 unique publishing
houses.
In addition to the survey, several other methods were
used to identify policy options and expert recommenda-
tions. First, keyword searches were conducted (e.g. “sex” +
“instructions for authors”) to identify journals that had
specific policies on sex and gender. In addition, we
scanned the websites of surveyed journals that explicitly
expressed concerns about sex and gender knowledge gaps
in science and the sex and gender reporting policies of
peer-reviewed journals already known to the Gender
Policy Committee.
Over a 3-year period, the Committee worked through
a series of teleconferences, conference presentations and
a 2-day workshop to develop its recommendations. Once
the draft guidelines were developed, dissenting views
were considered at editors’ meetings in Blankenberge,
Belgium, and Split, Croatia. In addition, the draft guide-
lines were circulated to 36 experts in sex and gender re-
search; any comments received were incorporated into
the document where relevant.
Results
Survey findings
The average proportion of respondents in each of the
four samples who reported having sex and/or gender
policies at their journals was 7 %. Respondents from
countries where men and women are more equal (lower
GII) were more likely to report that these policies are in
place.
In the random sample of 100 journals and the EASE
and ISAJE groups, a majority (75 %) were unsure or
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requirements in Instructions for Authors. Female re-
spondents were more likely to support sex and gender
reporting policies than male respondents. While caution
must be exercised in relation to the conclusions drawn,
the survey results point to the paucity of sex- and
gender-related policies concerning instructions for au-
thors, guidelines for peer-reviewers and gender balance
of both editorial boards and peer-reviewers.Literature review
Our review identified policies developed and used by 62
journals, as well as 25 other sources of published mate-
rials in the form of journal articles, editorials, expert
committee reports and conference proceedings.
The majority of sex and gender policies and guidelines
fell into the Instructions for Authors category, covering
a variety of scientific areas (e.g. “animal science,” “health –
psychiatry”) and types of research (e.g. animal, human, cell
or a combination of the three). In most cases, the instruc-
tions merely advise authors to report results for males and
females separately, if appropriate.
Several journals [20, 27, 5] have used their editorial
pages to announce the adoption of new policies or to
promote the need for greater awareness of sex and gen-
der issues. For example, the editors of Clinical Ortho-
paedic and Related Research published an editorial [5]
recommending that researchers seeking publication in
the journal use the following guidelines: (1) design studies
that are sufficiently powered to answer research questions
both for males and females if the health condition being
studied occurs in all sexes and genders; (2) provide sex-
and/or gender-specific data where relevant in all clinical,
basic science and epidemiological studies; (3) analyse the
influence (or association) of sex or gender on the results
of the study, or indicate in the “Methods” section why
such analyses were not performed, and consider this topic
as a limitation to cover in the “Discussion” section and (4)
if sex or gender analyses were performed post hoc, indi-
cate that these analyses should be interpreted cautiously.
In a 2011 workshop “Sex-specific reporting of scien-
tific research,” a broad cross section of stakeholders con-
vened by the US Institute of Medicine identified key
issues that journals and journal editors should address,
such as requiring authors to report on the sex of study
subjects, not only in studies with human participants
but also in animal research and in studies with cells, tis-
sues and other material from humans or animals.
Doull et al. [21] proposed that the methodologies of
systematic reviews and of sex- and gender-based analysis
be refined and synchronized to enhance the collection,
synthesis and analysis of evidence for decision-making.
Nowatski and Grant [23] provided a rationale for gender-based analysis (GBA), which is designed to identify the
sources and consequences of inequalities between women
and men and to develop strategies to address them. GBA
focuses on gender differences in health and health care
and appropriate policies.SAGER guidelines
The policies, procedures and recommendations reviewed
above were used as a basis for the SAGER guidelines,
which are designed to promote systematic reporting of
sex and gender in research. The guidelines provide re-
searchers and authors with a tool to standardize sex and
gender reporting in scientific publications, whenever
appropriate. They are also aimed at editors to use as a
practical instrument to evaluate a research manuscript
and as a vehicle to raise awareness among authors and
reviewers. Although reporting guidelines typically focus
on how to report what was actually done in a study, we
recognize that not all of the items included in the
SAGER guidelines are feasible or applicable to a particular
study. For this reason, SAGER encourages authors, editors
and referees to consider if sex and gender are relevant to
the topic of the study, and accordingly to follow the guide-
lines, whenever applicable. As a general principle, the
SAGER guidelines recommend careful use of the words sex
and gender in order to avoid confusing both terms. The use
of common definitions will improve the ability to conduct
meta-analyses of published and archived data. The term sex
should be used as a classification of male or female based
on biological distinction to the extent that this is possible
to confirm. Authors should underline in the methods
section whether sex of participants was defined based
on self-report, or assigned following external or internal
examination of body characteristics, or through genetic
testing or other means. In studies of animals, the term sex
should be used. In cell biological, molecular biological or
biochemical experiments, the origin and sex chromosome
constitutions of cells or tissue cultures should be stated. If
unknown, the reasons should be stated. In other disci-
plines, such as the testing of devices or technology, au-
thors should explain whether it will be applied or used by
all genders and if it has been tested with a user’s gender in
mind.
It is acknowledged that many studies will not have
been “designed” to analyse sex and/or gender differences,
but the panel felt these analyses are necessary to advance
knowledge about sex and gender, especially in medical
research.
Table 1 presents the SAGER guidelines. They apply to
all research with humans, animals or any material origin-
ating from humans and animals (e.g. organs, cells, tissues),
as well as other disciplines whose results will be applied to
humans such as mechanics and engineering.
Table 1 Sex and Gender Equity in Research (SAGER) guidelines
General principles
• Authors should use the terms sex and gender carefully in order to
avoid confusing both terms.
• Where the subjects of research comprise organisms capable of
differentiation by sex, the research should be designed and conducted
in a way that can reveal sex-related differences in the results, even if
these were not initially expected.
• Where subjects can also be differentiated by gender (shaped by social
and cultural circumstances), the research should be conducted similarly
at this additional level of distinction.
Recommendations per section of the article
Title and
abstract
If only one sex is included in the study, or if the results
of the study are to be applied to only one sex or
gender, the title and the abstract should specify the sex
of animals or any cells, tissues and other material derived
from these and the sex and gender of human
participants.
Introduction Authors should report, where relevant, whether sex and/
or gender differences may be expected.
Methods Authors should report how sex and gender were taken
into account in the design of the study, whether they
ensured adequate representation of males and females,
and justify the reasons for any exclusion of males or
females.
Results Where appropriate, data should be routinely presented
disaggregated by sex and gender. Sex- and gender-based
analyses should be reported regardless of positive or
negative outcome. In clinical trials, data on withdrawals
and dropouts should also be reported disaggregated
by sex.
Discussion The potential implications of sex and gender on the
study results and analyses should be discussed. If a sex
and gender analysis was not conducted, the rationale
should be given. Authors should further discuss the
implications of the lack of such analysis on the
interpretation of the results.
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If only one sex or gender is included in the study, the
title and the abstract should specify the sex of animals
or any cells, tissues and other material derived from
these and the sex and gender of human participants. In
applied sciences (technology, engineering, etc.), authors
should indicate if the study model was based on one sex
or the application was considered for the use of one spe-
cific sex. For studies (of a non-sex-specific issue) in
which only one sex has been used, the article’s title
should specify this fact by including “in males” or “in fe-
males” in the title and abstract. If cultures of primary
cells, tissue, etc., were obtained from one sex, the sex
should be indicated in the title [3].
Introduction
Authors should report, where relevant, previous studies
that show presence or lack of sex or gender differencesor similarities. If such studies are lacking, the authors
should explain whether sex and/or gender may be an
important variant and if differences may be expected.Methods
Authors should report how sex and gender were taken
into account in the design of the study, ensure adequate
representation of males and females and justify reasons
for the exclusion of males or females. Methodological
choices about sex and gender in relation to study popula-
tion and analytical approach should be reported and justi-
fied in the same way as other methodological choices.
In vivo and in vitro studies using primary cultures of
cells, or cell lines from humans or animals, or ex vivo
studies with tissues from humans or animals must state
the sex of the subjects or source donors, except for im-
mortalized cell lines, which are highly transformed [3].
In other cases, e.g. embryonic or early postnatal cultures,
cell lines immortalized from a mixed culture or previously
completed experiments for which sex was not documented,
it is recommended that researchers determine the sex of
cells or cell lines by chromosomal analysis and that the des-
ignations “mixed” or “unknown” should be used only when
the sex cannot be determined through any methods.Results
Data should be reported disaggregated by sex, and an
analysis of sex and gender differences and similarities
should be described, where appropriate. Anatomical and
physiological differences between men and women (height,
weight, body mass, cell counts, hormonal cycles, etc.) as
well as social and cultural variables (socio-economic status,
education, etc.) should be taken into consideration in the
presentation of data and/or analysis of the results. We rec-
ommend the use of the gendered innovations’ checklist for
animals, tissues, cells and cultures [28]. If sex- and gender-
based analyses have been performed, results should be re-
ported regardless of the positive or negative outcome. In
human studies, data on enrolment, participation, dropout,
discontinuation and loss-to-follow up should be reported
disaggregated by sex and gender (where appropriate), and
the influence of sex and gender factors should be assessed a
priori on the basis of their hypothesized role in the caus-
ation, course, treatment effectiveness, impact and outcome
of health problems. Authors should refrain from conduct-
ing a post hoc gender-based analysis if the study design is
insufficient to enable meaningful conclusions. In all cases,
raw data should be published disaggregated by sex and gen-
der for future pooling and meta-analysis.
In epidemiological studies, the impact of other exposures,
such as socioeconomic variables, on health problems
should be examined for all genders and should be analysed
critically from a gender perspective.
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to report what was actually done. However, not all of the
items in the SAGER guidelines need to be done, as indi-
cated by the words, “if appropriate.” The SAGER guide-
lines are intended to promote sex and gender equity in
research; therefore, it encourages authors, editors and
referees to consider if sex and gender are relevant to the
topic of the study, and accordingly to follow the guide-
lines, whenever applicable.Discussion
The implications of sex and gender for the interpretation
of study results should be elaborated, including the ex-
tent to which the findings can be generalized to all sexes
and genders in a population. If no sex and gender-based
analyses have been performed, authors should indicate
the reasons for lack of such analyses when discussing
the limitations of the study and discuss whether such
analyses could have affected the results.
When interpreting research findings, past research
should be examined for both methodological rigour and
sex bias in procedure and interpretation. Authors should
avoid confusing sex with gender and reducing complex
or interactionist explanations to overly simple ones. Au-
thors should consider all possible explanations for sex-
and gender-related phenomena including social, cultural,
biological and situational factors, recognizing that many
sex-related behaviours might result from either cultural
factors or biological factors. Covariation between biology
and behaviour does not constitute evidence for physio-
logical causation.4. DISCUSSION/L
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Fig. 1 SAGER flowchart guiding editors’ initial screening of submitted manAppendix 2 provides a set of questions intended to
raise awareness among authors. For many disciplines
engaged in original scientific research, this list could
serve as a basis for the preparation of a manuscript for
submission.
Conclusions
The SAGER guidelines were developed over a 3-year
period by a multidisciplinary group of academics, scien-
tists and journal editors by means of literature reviews,
expert feedback and public consultations at conferences.
Authors, journal editors, publishers, reviewers and other
members of the scientific community all have a role to
play in addressing the neglect of the sex and gender di-
mension in scientific publishing.
The SAGER guidelines provide researchers and au-
thors with a tool to standardize sex and gender reporting
in scientific publications. They were designed to improve
sex and gender reporting of scientific research, serve as
a guide for authors and peer-reviewers, be flexible enough
to accommodate a wide range of research areas and
disciplines and improve the communication of research
findings. Nevertheless, the guidelines do not make explicit
recommendations regarding gender-diverse populations.
We recognize that most studies will not be powered to de-
tect differences in effects for gender-diverse populations
such as transgender, especially in countries where such
diversity is unknown. Yet authors need to consider the
relevance of their research for gender-diverse populations.
Editors should make it clear that integration of sex
and gender issues makes for more rigorous and ethical
science. To the extent that mandates are difficult toIMITATION
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the SAGER guidelines and adapt them to the needs of
their journals and their fields of science by including ex-
amples of good practice for each of the reporting items.
At a minimum, journals publishing original research
should request in their instructions to authors that all
papers present data disaggregated by sex and gender
and, where applicable, explain sex and gender differences
or similarities adequately. Figure 1 provides a list of
questions that could be used to guide the initial screen-
ing of submitted manuscripts. Editors should introduce
specific questions in the checklist used to screen initial
submissions, as an effort to systematize gender-conscious
assessment of manuscripts among editorial staff. The fol-
lowing is an example of questions that can be introduced
in peer-reviewers’ assessment forms:
1. Are sex and gender relevant to the research in
question?
2. Have authors adequately addressed sex and gender
dimensions or justified absence of such analysis?
To be effective, the guidelines need to be endorsed
by a broad cross section of the scientific community,
including journal editors, publishers, editors’ societies,
professional organizations, scientific advocacy groups,
science journalists and other science communicators.
Editors should distribute the SAGER guidelines to
their reviewers and encourage them to use them in the
evaluation of manuscripts. They should ensure the
manuscript assessment forms completed by peer-reviewers
include specific questions regarding the importance and
relevance of sex and gender.
Training the editorial staff on the importance of sex
and gender-sensitive reporting should be conducted as
part of regular training on ethical conduct and editorial
practices.Appendix 1
Glossary of terms
Gender. Gender refers to the socially constructed roles,
behaviours and identities of female, male and gender-
diverse people [1]. It influences how people perceive
themselves and each other, how they behave and interact
and the distribution of power and resources in society.
Gender is usually incorrectly conceptualized as a binary
factor (female/male). In reality, there is a spectrum of
gender identities and expressions defining how individ-
uals identify themselves and express their gender.
Gender identity. A person’s concept of self as being
male and masculine or female and feminine, or ambiva-
lent, based in part on physical characteristics, parental
responses and psychological and social pressures. It is the
internal experience of gender role. (Mesh term, introduced
in 1991, revised in 1975).Gender-based analysis. An analytical tool that system-
atically integrates a gender perspective into the develop-
ment of policies, programmes and legislation, as well as
planning and decision-making processes. It helps to
identify and clarify the differences between women and
men and boys and girls and demonstrates how these dif-
ferences affect health status, access to, and interaction
with, the health care system.
(http://www.hc-sc.gc.ca/hl-vs/pubs/women-femmes/gender-
sexes-eng.php)
Gender-sensitive analysis. Analysis of statistics that
goes beyond simply disaggregating data according to sex
(e.g. a mere “sex-counting” is not sufficient). Gender-
sensitive analysis should question the underlying gender
relations which are reflected in the data.
(http://www.oecd.org/dac/gender-development/4489
6238.pdf )
Gender perspective. The gender perspective looks at
the impact of gender on people’s opportunities, social roles
and interactions. Successful implementation of the policy,
programme and project goals of international and national
organizations is directly affected by the impact of gender
and, in turn, influences the process of social development.
Gender is an integral component of every aspect of the
economic, social, daily and private lives of individuals and
societies and of the different roles ascribed by society to
men and women.
(http://www.fao.org/docrep/003/x2919e/x2919e04.htm)
Sex. Sex refers to a set of biological attributes in
humans and animals that are associated with physical
and physiological features including chromosomes, gene
expression, hormone function and reproductive/sexual
anatomy [1]. Sex is usually categorized as female or male,
although there is variation in the biological attributes that
constitute sex and how those attributes are expressed.
Sex- and Gender-Based Analysis. An analytical ap-
proach that integrates a sex and gender perspective into
the development of health research, policies and pro-
grammes, as well as health planning and decision-making
processes. It helps to identify and clarify the differences
between women and men and boys and girls and demon-
strates how these differences affect health status, access to,
and interaction with, the health care system.
(http://www.hc-sc.gc.ca/hl-vs/gender-genre/analys/
index-eng.php)
Sex-disaggregated data. Data that are collected and
presented separately on men and women. Gender Main-
streaming Implementation Framework—UNESCO, 2003.
Sexism. Prejudice or discrimination based on gender
or behaviour or attitudes that foster stereotyped social
roles based on gender. (MESH term, introduced in 2013).
Transgender Persons, Transexual persons, Transgenders.
Persons having a sense of persistent identification with,
and expression of, gender-coded behaviours not typically
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without a desire to undergo sex reassignment procedures
(MeSH term 2016 (2013).
Appendix 2Table 2 Authors’ checklist for gender-sensitive reporting
Research approaches ✓
✓ Are the concepts of gender and/or sex used in your research project?
✓ If yes, have you explicitly defined the concepts of gender and/or
sex? Is it clear what aspects of gender and/or sex are being
examined in your study?
✓ If no, do you consider this to be a significant limitation? Given
existing knowledge in the relevant literature, are there plausible
gender and/or sex factors that should have been considered? If
you consider sex and/or gender to be highly relevant to your
proposed research, the research design should reflect this
Research questions and hypotheses
✓ Does your research question(s) or hypothesis/es make reference
to gender and/or sex, or relevant groups or phenomena?
(e.g., differences between males and females, differences among
women, seeking to understand a gendered phenomenon such
as masculinity)
Literature review
✓ Does your literature review cite prior studies that support the
existence (or lack) of significant differences between women
and men, boys and girls, or males and females?
✓ Does your literature review point to the extent to which past
research has taken gender or sex into account?
Research methods
✓ Is your sample appropriate to capture gender and/or sex-based
factors?
✓ Is it possible to collect data that are disaggregated by sex and/or
gender?
✓ Are the inclusion and exclusion criteria well justified with respect
to sex and/or gender? (Note: this pertains to human and animal
subjects and biological systems that are not whole organisms)
✓ Is the data collection method proposed in your study appropriate
for investigation of sex and/or gender?
✓ Is your analytic approach appropriate and rigorous enough to
capture gender and/or sex-based factors?
Ethics
✓ Does your study design account for the relevant ethical issues that
might have particular significance with respect to gender and/or
sex? (e.g., inclusion of pregnant women in clinical trials)
Source: Adapted from Canadian Institutes of Health Research.Competing interests
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